Trilogy Mets

Forecast & Rating6 analysts currently cover Trilogy Mets, with about 50.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $6.62, about 103.2% upside from the current price of $3.26. Price targets range from $4.36 to $10.02 — a wide spread, showing clear disagreement over just how much Trilogy Mets can rise. Historically, about 37.7% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Trilogy Mets are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Sep 8, 2026; for reference only and not investment advice.